Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-05

Clinical Trial Update: Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at Altitude [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether acetazolamide affects lung water content by ultrasound in patients with chronic obstructive pulmonary disease at altitude; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED